Needle Penetration Detection Method and Device for Refillable and Implantable Drug Delivery Systems

• US 20140228765A1
• Filed: 02/04/2014
• Published: 08/14/2014
• Est. Priority Date: 02/11/2013
• Status: Abandoned Application

• Current Assignee: Flowonix Medical, Inc.
• Original Assignee: Flowonix Medical, Inc.
• Inventors: BURKE, Paul, ADLER, Steve, HANSEN, Robert M.
• Application Number:
  US14/171,840
• Publication Number:
  US 20140228765A1
• Time in Patent Office: Days
• US Class Current: 604/181
• CPC Class Codes: A61M 2039/0226 having means for protecting the interior of the access site from damage due to the insertion of a needle
• CPC Class Codes: A61M 2039/0244 having means for detecting an inserted needle
• CPC Class Codes: A61M 39/0208 Subcutaneous access sites for injecting or removing fluids transcutaneous access sites A61M39/0247; implantable infusion devices A61M5/14276
• CPC Class Codes: A61M 5/14276 specially adapted for implantation

Abstract

A refillable and implantable infusion apparatus and method that includes a needle penetration detector that detects and indications the position of a needle relative to a septum of a drug reservoir of the implantable infusion apparatus. With the needle position data, medical professionals may better ensure they are injecting drugs into the drug reservoir, thus, improving patient safety.

Claims

1. A method for detecting a needle penetration into a septum of a refillable implantable drug delivery system, comprising:

obtaining a baseline measurement of inductance of a needle penetration detector within the septum of a refillable implantable drug delivery system prior to a needle penetration of a patient;

obtaining a measurement of the inductance of the needle penetration detector following a needle penetration of the patient;

comparing the measurement of inductance to the baseline measurement of inductance;

determining whether the difference between the baseline measurement of inductance and the measurement of inductance satisfies a threshold;

indicating the needle did not penetrate the septum in response to determining that the difference between the baseline measurement and the measurement of inductance not satisfy the threshold; and

indicating the needle did penetrate the septum in response to determining that the difference between the baseline measurement and the measurement of inductance satisfies the threshold.

2. A refillable implantable drug delivery system, comprising:

a refill septum;

an induction coil surrounding the refill septum;

an inductance measuring circuit connected to the induction coil;

a wireless communication transceiver; and

a processor coupled to the inductance measuring circuit and the wireless communication transceiver, wherein the processor is configured with processor-executable instructions to perform operations comprising;

obtaining a base line measurement of inductance of the induction coil;

obtaining a measurement of the inductance of the induction coil;

determining whether a difference between the baseline measurement of inductance and the measurement of inductance satisfies a first threshold;

transmitting a signal via the wireless communication transceiver indicating that a needle did not penetrate the refill septum in response to determining that the difference between the baseline measurement and the measurement of inductance does not satisfy the first threshold; and

transmitting a signal via the wireless communication transceiver indicating that the needle did penetrate the refill septum in response to determining that the difference between the baseline measurement and the measurement of inductance satisfies the first threshold.

3. The refillable implantable drug delivery system of claim 2, wherein the processor is configured with processor-executable instructions to perform operations further comprising transmitting a signal via the wireless communication transceiver indicating that the needle is near the septum upon determining that the difference between the baseline measurement and the measurement of inductance satisfies a second threshold that is different from the first threshold.

4. A refillable implantable drug delivery system, comprising:

a refill septum;

an induction coil surrounding the refill septum;

means for obtaining a base line measurement of inductance of the induction coil;

means for obtaining a measurement of the inductance of the induction coil;

means for determining whether a difference between the baseline measurement of inductance and the measurement of inductance satisfies a first threshold;

means for transmitting a signal indicating that a needle did not penetrate the refill septum in response to determining that the difference between the baseline measurement and the measurement of inductance does not satisfy the first threshold; and

means for transmitting a signal indicating that the needle did penetrate the refill septum in response to determining that the difference between the baseline measurement and the measurement of inductance satisfies the first threshold.

5. The refillable implantable drug delivery system of claim 4, further comprising:

means for transmitting a signal indicating that the needle is near the refill septum upon determining that the difference between the baseline measurement and the measurement of inductance satisfies a second threshold that is different from the first threshold.